| Application number | Title of the application | Filing Date | Status |
|---|
| 08/611390 | SELECTIVELY N-ALKYLATED PEPTIDOMIMETIC COMBINATORIAL LIBRARIES AND COMPOUNDS THEREIN | Mar 4, 1996 | Abandoned |
Array
(
[id] => 4197220
[patent_doc_number] => 06013531
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-11
[patent_title] => 'Method to use fluorescent magnetic polymer particles as markers in an immunoassay'
[patent_app_type] => 1
[patent_app_number] => 8/518135
[patent_app_country] => US
[patent_app_date] => 1995-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 10083
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 337
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/013/06013531.pdf
[firstpage_image] =>[orig_patent_app_number] => 518135
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/518135 | Method to use fluorescent magnetic polymer particles as markers in an immunoassay | Aug 21, 1995 | Issued |
Array
(
[id] => 3633150
[patent_doc_number] => 05631158
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-20
[patent_title] => 'Methods and compositions for high protein production from non-native DNA'
[patent_app_type] => 1
[patent_app_number] => 8/461184
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13046
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/631/05631158.pdf
[firstpage_image] =>[orig_patent_app_number] => 461184
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461184 | Methods and compositions for high protein production from non-native DNA | Jun 4, 1995 | Issued |
Array
(
[id] => 3532362
[patent_doc_number] => 05556770
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-17
[patent_title] => 'Method of preparing a composition that enhances'
[patent_app_type] => 1
[patent_app_number] => 8/430119
[patent_app_country] => US
[patent_app_date] => 1995-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4682
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/556/05556770.pdf
[firstpage_image] =>[orig_patent_app_number] => 430119
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/430119 | Method of preparing a composition that enhances | Apr 26, 1995 | Issued |
Array
(
[id] => 3627510
[patent_doc_number] => 05621083
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Immunotoxins comprising ribosome-inactivating proteins'
[patent_app_type] => 1
[patent_app_number] => 8/425336
[patent_app_country] => US
[patent_app_date] => 1995-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 46479
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/621/05621083.pdf
[firstpage_image] =>[orig_patent_app_number] => 425336
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/425336 | Immunotoxins comprising ribosome-inactivating proteins | Apr 17, 1995 | Issued |
| 08/416543 | ANTIBODIES TO VASCULAR ENDOTHELIAL CELL GROWTH FACTOR | Mar 28, 1995 | Abandoned |
| 08/378912 | VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS | Jan 24, 1995 | Abandoned |
Array
(
[id] => 3653753
[patent_doc_number] => 05626844
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-06
[patent_title] => 'Monoclonal antibody against ricin A chain'
[patent_app_type] => 1
[patent_app_number] => 8/363204
[patent_app_country] => US
[patent_app_date] => 1994-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2265
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/626/05626844.pdf
[firstpage_image] =>[orig_patent_app_number] => 363204
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/363204 | Monoclonal antibody against ricin A chain | Dec 26, 1994 | Issued |
Array
(
[id] => 3619669
[patent_doc_number] => 05612032
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-18
[patent_title] => 'Method for diagnosing tumors using mouse monoclonal antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/363203
[patent_app_country] => US
[patent_app_date] => 1994-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4613
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/612/05612032.pdf
[firstpage_image] =>[orig_patent_app_number] => 363203
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/363203 | Method for diagnosing tumors using mouse monoclonal antibodies | Dec 21, 1994 | Issued |
Array
(
[id] => 3528521
[patent_doc_number] => 05541296
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-30
[patent_title] => 'Monocyte adhesion protein and monoclonal antibody thereto'
[patent_app_type] => 1
[patent_app_number] => 8/357535
[patent_app_country] => US
[patent_app_date] => 1994-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 4764
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/541/05541296.pdf
[firstpage_image] =>[orig_patent_app_number] => 357535
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/357535 | Monocyte adhesion protein and monoclonal antibody thereto | Dec 15, 1994 | Issued |
Array
(
[id] => 3998231
[patent_doc_number] => 06004549
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Crystalline protein controlled release compositions'
[patent_app_type] => 1
[patent_app_number] => 8/355585
[patent_app_country] => US
[patent_app_date] => 1994-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9182
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/004/06004549.pdf
[firstpage_image] =>[orig_patent_app_number] => 355585
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/355585 | Crystalline protein controlled release compositions | Dec 13, 1994 | Issued |
Array
(
[id] => 3625552
[patent_doc_number] => 05608039
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-04
[patent_title] => 'Single chain B3 antibody fusion proteins and their uses'
[patent_app_type] => 1
[patent_app_number] => 8/331398
[patent_app_country] => US
[patent_app_date] => 1994-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 40
[patent_no_of_words] => 25387
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/608/05608039.pdf
[firstpage_image] =>[orig_patent_app_number] => 331398
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/331398 | Single chain B3 antibody fusion proteins and their uses | Oct 27, 1994 | Issued |
Array
(
[id] => 3507522
[patent_doc_number] => 05514776
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-07
[patent_title] => 'Peptides representing antigenic epitopes of dog IgE present on B cell but not basophil surface'
[patent_app_type] => 1
[patent_app_number] => 8/326767
[patent_app_country] => US
[patent_app_date] => 1994-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4160
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/514/05514776.pdf
[firstpage_image] =>[orig_patent_app_number] => 326767
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/326767 | Peptides representing antigenic epitopes of dog IgE present on B cell but not basophil surface | Oct 19, 1994 | Issued |
| 08/324518 | IMMUNOTHERAPY INVOLVING CD28 STIMULATION | Oct 16, 1994 | Abandoned |
Array
(
[id] => 3690322
[patent_doc_number] => 05644036
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'Purified immunoglobulin'
[patent_app_type] => 1
[patent_app_number] => 8/319598
[patent_app_country] => US
[patent_app_date] => 1994-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 8364
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/644/05644036.pdf
[firstpage_image] =>[orig_patent_app_number] => 319598
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/319598 | Purified immunoglobulin | Oct 6, 1994 | Issued |
Array
(
[id] => 3610546
[patent_doc_number] => 05589573
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-31
[patent_title] => 'Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and DNA base sequences encoding those sequences'
[patent_app_type] => 1
[patent_app_number] => 8/318970
[patent_app_country] => US
[patent_app_date] => 1994-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9704
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/589/05589573.pdf
[firstpage_image] =>[orig_patent_app_number] => 318970
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/318970 | Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and DNA base sequences encoding those sequences | Oct 5, 1994 | Issued |
| 08/256375 | HUMANISED ANTIBODIES DIRECTED AGAINST A33 ANTIGEN | Oct 3, 1994 | Abandoned |
| 08/307868 | RECOMBINANT PEPTIDES DERIVED FROM THE MC3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES | Sep 15, 1994 | Abandoned |
Array
(
[id] => 3525220
[patent_doc_number] => 05541087
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-30
[patent_title] => 'Expression and export technology of proteins as immunofusins'
[patent_app_type] => 1
[patent_app_number] => 8/305700
[patent_app_country] => US
[patent_app_date] => 1994-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 10581
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/541/05541087.pdf
[firstpage_image] =>[orig_patent_app_number] => 305700
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/305700 | Expression and export technology of proteins as immunofusins | Sep 13, 1994 | Issued |
| 08/304440 | PURIFIED IMMUNOGLOBULIN | Sep 11, 1994 | Abandoned |